Diabetic Vasculopathy: Molecular Mechanisms and Clinical Insights.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic pathways without systematic search or meta-analytic data.
PubMed 38255878 · doi:10.3390/ijms25020804
What was done
Narrative review synthesizing preclinical and clinical literature regarding the relationship between insulin resistance, diabetes mellitus, and diabetic vasculopathy (both microvascular and macrovascular complications). The authors summarize underlying cellular and molecular mechanisms, epidemiology, clinical characteristics, and therapeutic strategies.
What was found
The abstract reports no quantitative data, effect sizes, or statistical metrics. It describes qualitative associations and mechanisms including renin-angiotensin-aldosterone system overactivation, mitochondrial dysfunction, oxidative stress, inflammation, dyslipidemia, thrombosis, endothelial progenitor cell dysfunction, gut dysbiosis, and aberrant extracellular vesicle-microRNA signaling.
Why it matters
It consolidates current mechanistic models linking metabolic dysfunction to vascular injury, outlining biological pathways that could serve as targets for preventing diabetic cardiovascular disease.
Limits
As a narrative review, it lacks a systematic search protocol, study selection criteria, risk-of-bias evaluation, and quantitative synthesis. The abstract provides no primary human empirical data or numerical findings.
Cited by
- context Elevated glucose levels primarily damage small blood vessels while elevated insulin levels primarily damage large blood vessels.